Flexion Therapeutics to Present at the Oppenheimer 31st Annual Virtual Healthcare Conference
Flexion Therapeutics (Nasdaq:FLXN) announced that CEO Michael Clayman will participate in an analyst-led fireside chat at the Oppenheimer 31st Annual Healthcare Conference. The virtual event is set for 10:00 a.m. ET on March 17, 2021. Interested parties can access the live webcast through the Flexion website.
Flexion specializes in developing and commercializing innovative therapies for musculoskeletal conditions, focusing on osteoarthritis.
- None.
- None.
BURLINGTON, Mass., March 15, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Oppenheimer 31st Annual Healthcare Conference. The virtual fireside chat is scheduled to begin at 10:00 a.m. ET on Wednesday, March 17, 2021.
To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.
Contact:
Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com
FAQ
When will Flexion Therapeutics' fireside chat take place?
Who is participating in the Oppenheimer Healthcare Conference from Flexion Therapeutics?
How can I access the live webcast of Flexion Therapeutics' presentation?
What is the focus of Flexion Therapeutics?
What is the stock symbol for Flexion Therapeutics?
